PExAenters into a research collaboration agreement with Janssen and the Universityof Gothenburg for discovery of biomarkers in exhaled air
Swedish medical technology company PExA AB(“PExA”) announced that it has entered into a research collaboration agreement withJanssen Research & Development, LLC, one of the Janssen PharmaceuticalCompanies of Johnson & Johnson, and the University of Gothenburg.biomarker discovery, was recently selected Awardee of the Carcinogenic Exposure Meter Quickfire Challenge. The Challenge was launched by Johnson & Johnson Innovation, the Lung Cancer Initiative (LCI) at Johnson & Johnson, and Janssen in an effort to help reduce the tobacco epidemic. As part of the collaboration, Janssen will